Sign in
4

Changes in Ownership

AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001096906-22-002330

Options or other derivatives

  • Chief Executive Officer returned 2,000,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HUEMOELLER JOHN WALTER II Chief Executive Officer 2021-05-06 Returned to the company · Option −2,000,000 3,000,000 D
Loading xslF345X03/form4.xml…